Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 7—July 2005
Dispatch

Asymptomatic SARS Coronavirus Infection among Healthcare Workers, Singapore

Annelies Wilder-Smith*Comments to Author , Monica D. Teleman*, Bee H. Heng†, Arul Earnest*, Ai E. Ling‡, and Yee S. Leo*
Author affiliations: *Tan Tock Seng Hospital, Singapore; †National Healthcare Group, Singapore; ‡Singapore General Hospital, Singapore

Main Article

Table 2

Univariate analysis of risk factors associated with asymptomatic versus pneumonic SARS*†

Variable Asymptomatic SARS Pneumonic SARS p value‡ Controls p value§
Median antibody titer (range) 1: 4,000 (1:400–1:6,400) 1:6,400 (1:1,600–1:6,400) 0.013¶ NA NA
Mean age (SD) 26.5 (4.3) 29.6 (9.2) 0.706¶ 33.7 (11.5) 0.098#
Females (%) 6 (100) 32 (86) >0.999 49 (94) 0.321
No. who used masks (%) 3 (50) 3 (8) 0.025 21 (40) 0.002
No. who used gloves (%) 1 (17) 10 (26) >0.999 24 (46) 0.090
No. who washed hands (%) 4 (67) 29 (76) 0.63 47 (90) 0.110
No. who were close to a SARS patient (≤3 ft), % 5 (83) 35 (92) 0.456 48 (92) 0.747
Median contact time in minutes (range) 67.5 (10–360) 60 (10–480) 0.863¶ 30 (10–960) 0.879#

*SARS, severe acute respiratory syndrome; NA, not available.
†SARS serology–negative asymptomatic controls added for comparison. All p values from Fisher exact test or chi-square test, unless otherwise stated.
‡p value for comparing asymptomatic versus pneumonic SARS.
§p value for comparing any 2 pairs in the 3 groups. For multiple comparisons, level of significance was set at 0.017 using the Bonferroni method.
¶p values from Mann-Whitney test.
#p values from Kruskal-Wallis test.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external